Opioids

A new study reveals that when physicians are under time constraints it can greatly impact their treatment decisions.  

Study shows a significant portion of overdoses in the U.S. mortality data is missing information on specific drugs involved.

Information gleaned will be crucial to providers, insurers, and policy makers.

Up to 15 clinics are set to open nationwide in the next year.

Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study

The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.

Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes

A new study has revealing findings about the effects of front-end opioid prescribing for knee, hip, and shoulder joint replacement patients.

A new survey shows that while many healthcare executives recognize drug diversion as a problem, few admit to it happening in their organization.

In the first of many similar cases, the trial of Oklahoma versus Johnson & Johnson could frame who is to blame for the opioid epidemic.

Access to broad snapshot of the patient’s pharmacy and medical data can help spot and address drug misuse.

A new study suggests that the FDA and manufacturers did not act when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.

WalletHub released a study on Highest Drug Use by State to highlight the areas that stand to be most affected. Here are the top 10.

Here are certain facts that every executive responsible for managing populations at risk for prescription drug misuse should know as they make policy decisions affecting patient care and financial management.

While we all want to predict the future so we can avoid obstacles, we cannot allow our desire for clarity to become an obstacle itself.

A survey from Vizient identifies top strategies for the treatment of pain.

Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.

Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.

Here are 4 key ways healthcare executives can leverage community resources to strengthen the availability of tools that support recovery from opioid addiction.

This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.

Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.

A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.

Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.

Ball State University study: A severe shortage of mental health professionals in rural areas, as well as opioid and drug problems, is a major concern.

A new report is making some healthcare executives a bit more optimistic about efforts to curb the opioid epidemic. Find out why.